Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Vera Therapeutics Inc (NASDAQ: VERA) was $47.27 for the day, down -2.15% from the previous closing price of $48.31. In other words, the price has decreased by -$2.15 from its previous closing price. On the day, 0.52 million shares were traded. VERA stock price reached its highest trading level at $49.47 during the session, while it also had its lowest trading level at $46.545.
Ratios:
Our analysis of VERA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.60 and its Current Ratio is at 13.60. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on November 21, 2024, initiated with a Overweight rating and assigned the stock a target price of $70.
On January 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.Oppenheimer initiated its Outperform rating on January 25, 2024, with a $26 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 25 ’24 when MARSHALL FORDYCE bought 19,375 shares for $48.31 per share.
Fordyce Marshall sold 30,625 shares of VERA for $1,516,037 on Nov 13 ’24. The PRESIDENT AND CEO now owns 85,942 shares after completing the transaction at $49.50 per share. On Nov 13 ’24, another insider, MARSHALL FORDYCE, who serves as the Director of the company, bought 30,625 shares for $48.54 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2993283072 and an Enterprise Value of 2760737792.
Stock Price History:
Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $12.28. The 50-Day Moving Average of the stock is 8.37%, while the 200-Day Moving Average is calculated to be 16.02%.
Shares Statistics:
VERA traded an average of 748.90K shares per day over the past three months and 684800 shares per day over the past ten days. A total of 63.32M shares are outstanding, with a floating share count of 46.84M. Insiders hold about 26.04% of the company’s shares, while institutions hold 77.46% stake in the company. Shares short for VERA as of 1730332800 were 6389681 with a Short Ratio of 8.53, compared to 1727654400 on 6170825. Therefore, it implies a Short% of Shares Outstanding of 6389681 and a Short% of Float of 13.859999.